Colossal Biosciences reportedly in talks to raise new capital at $20B 30B valuation

TITLE: Colossal Biosciences reportedly in talks to raise new capital at $20B 30B valuation

Big move in AI today. Colossal Biosciences reportedly in talks to raise new capital at — and it could change how you think about this space. Here is what happened and why it matters.

So here is the first thing — Colossal Biosciences reportedly in talks to raise new capital at $20B 30B valuation. The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Meanwhile — Trump’s latest AI czar has already resigned. The director role for the Center for AI Standards and Innovation (CAISI) has become a revolving door since David Sacks left his position as czar.

And then there is this — Why are gasoline prices rising faster than oil prices? Blame it on the ‘crack.’. The spread between the cost of barrels of gasoline and crude oil — known as the “crack spread” — has widened sharply.

The bigger picture is simple: Colossal Biosciences reportedly in talks to raise new capital at $20B 30B valuation is no longer a one-off headline. It is turning into a broader AI shift people will keep talking about.

This matters because Colossal Biosciences reportedly in talks to raise new capital at $20B 30B valuation is shaping what people will expect from AI tools next. That makes it useful content for a broad audience, not just niche insiders.

That is the short version of what is happening with Colossal Biosciences reportedly in talks to raise new capital at $20B 30B valuation. If you found this useful, follow for more AI updates that actually make sense.

- Source 1: Colossal Biosciences reportedly in talks to raise new capital at $20B 30B valuation

- Source 2: Trump’s latest AI czar has already resigned

- Source 3: Why are gasoline prices rising faster than oil prices? Blame it on the ‘crack.’